Explore

Trendline Trendline
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead R Strategy

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead R Strategy

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead R Strategy
Trendline Trendline
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Drive R Innovation

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Drive R Innovation

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Drive R Innovation
Trendline Trendline
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Trendline Trendline
Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials
Trendline Trendline
Halia Therapeutics Expands Leadership as It Advances Inflammation Therapies

Halia Therapeutics Expands Leadership as It Advances Inflammation Therapies

Halia Therapeutics Expands Leadership as It Advances Inflammation Therapies
Trendline Trendline
OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data

OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data

OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data
Trendline Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board

TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board

TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
Trendline Trendline
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy

Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy

Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Trendline Trendline
CEL-SCI Reports Progress in Multikine Development and Financial Results

CEL-SCI Reports Progress in Multikine Development and Financial Results

CEL-SCI Reports Progress in Multikine Development and Financial Results
Trendline Trendline
HotSpot Therapeutics to Present Preclinical Data on IRF5 Inhibitor at EULAR 2026

HotSpot Therapeutics to Present Preclinical Data on IRF5 Inhibitor at EULAR 2026

HotSpot Therapeutics to Present Preclinical Data on IRF5 Inhibitor at EULAR 2026
Trendline Trendline
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics

Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics

Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics